Kelli M Gingerich is a Philadelphia, Pennsylvania based nurse practitioner who is specialized as Adult Health nurse. Her current practice location is 3400 Civic Center Blvd, 2nd Floor, Philadelphia. Patients can reach her at 215-615-0063 with specialization in Adult Health and her NPI number (Unique professional ID assigned by NPPES) is 1316483530. Kelli M Gingerich can evaluate, diagnose patients overall wellness, and conditions such as cancer, heart disease, diabetes, arthritis, sports injuries, and other ailments. She can see patients and promote healthy living and wellness. She can perform physical examinations, order and interpret tests, prescribe medications and treatments, and can also provide education and counseling to patients on wellness strategies and disease prevention.
Complete Profile:
Kelli M Gingerich speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
Name:
Kelli M Gingerich
Specialization:
Adult Health Nurse Practitioner (ANP)
Gender:
Female
Practice Address:
3400 Civic Center Blvd, 2nd Floor, Philadelphia, Pennsylvania, 19104-5127
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1316483530
NPI Enumeration Date:
11 Jan, 2017
NPI Last Update On:
11 Jan, 2017
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Kelli M Gingerich 3400 Civic Center Blvd, 2nd Floor Philadelphia, Pennsylvania
Zip:
19104-5127
Patients can reach Kelli M Gingerich at 3400 Civic Center Blvd, 2nd Floor, Philadelphia, Pennsylvania or can call to book an appointment on 215-615-0063.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 September, 2024.